Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Product sales, net $ 5,564 $ 12,603 $ 19,230 $ 44,368
Cost of goods sold 3,106 4,175 10,442 13,430
Gross Profit 2,458 8,428 8,788 30,938
Operating expenses:        
Research and development 412 1,544 2,667 4,574
Selling, general and administrative 5,197 8,657 19,249 36,261
Total operating expenses 5,609 10,201 21,916 40,835
Operating Loss (3,151) (1,773) (13,128) (9,897)
Other Expenses [Abstract]        
Interest (income) expense, net 6 (7) 0 (2)
Income loss before income taxes (3,157) (1,766) (13,128) (9,895)
Income tax expense (benefit) 0 3 (138) 29
Net Loss $ (3,157) $ (1,769) $ (12,990) $ (9,924)
Weighted average common shares outstanding, basic and diluted (shares) 99,950 98,733 99,831 97,524
Net loss per common share, basic and diluted (in USD per share) $ (0.03) $ (0.02) $ (0.13) $ (0.10)
Revenue, Product and Service [Extensible List]     us-gaap:ProductMember